The Lausanne University Hospital, in Lausanne, is one of the five university hospitals in Switzerland. The Lausanne University Hospital is linked to the Faculty of Biology and Medicine of the University of Lausanne. The CHUV's medical services benefit over 45,000 patients a year.

There are 1,568 beds in Centre Hospitalier Universitaire Vaudois.

During the past decade, Centre Hospitalier Universitaire Vaudois conducted 262 clinical trials. In the 10-year time frame, 262 clinical trials started and 56 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 118 clinical trials started and 31 clinical trials were completed. i.e. 26.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Universitaire Vaudois" #1 sponsor was "Centre Hospitalier Universitaire Vaudois" with 62 trials, followed by "Swiss Group for Clinical Cancer Research" with 50 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 48 trials sponsored, "ETOP IBCSG Partners Foundation" with 15 trials sponsored and "University of Lausanne Hospitals" with 15 trials sponsored. Other sponsors include 295 different institutions and companies that sponsored additional 182 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Universitaire Vaudois" #1 collaborator was "Centre Hospitalier Universitaire Vaudois" with 20 trials as a collaborator, "University Hospital, Geneva" with 10 trials as a collaborator, "University of Bern" with 8 trials as a collaborator, "Breast International Group" with 6 trials as a collaborator and "National Cancer Institute (NCI)" with 6 trials as a collaborator. Other collaborators include 327 different institutions and companies that were collaborators in the rest 264 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Universitaire Vaudois" are "Breast Cancer" (28 trials), "Lymphoma" (13 trials), "Brain and Central Nervous System Tumors" (10 trials), "Lung Cancer" (10 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "Centre Hospitalier Universitaire Vaudois" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Universitaire Vaudois" are "Drug" (260 trials), "Other" (82 trials), "Procedure" (63 trials), "Device" (61 trials) and "Biological" (57 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "cyclophosphamide" (17 trials), "radiation therapy" (17 trials), "doxorubicin hydrochloride" (14 trials) and "conventional surgery" (13 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Universitaire Vaudois" are 427 trials for "All" genders, 41 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are 144 active trials in "Centre Hospitalier Universitaire Vaudois". 2 are not yet recruiting, 92 are recruiting, 46 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 250 completed trials in Centre Hospitalier Universitaire Vaudois, 2 suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Universitaire Vaudois, 43 "Phase 1" clinical trials were conducted, 120 "Phase 2" clinical trials and 135 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 106 trials that are defined as “Not Applicable".